Minnesota medical marijuana patients are worried after news broke that one of the state’s two cannabis providers is experiencing a distribution delay, leaving them with scarce supplies for treatment.
Tag Archives: Andrew Bachman
Minnesota’s two licensed medical marijuana manufacturers have lost a combined $11 million in just two years of sales, according to financial documents obtained by the Associated Press
Medical-marijuana startup LeafLine Labs has begun an effort to raise $21 million, according to a regulatory filing.
When medical marijuana becomes available in Minnesota on July 1, two state-approved companies will begin selling cannabis in pill and oil form to patients who suffer from cancer, HIV, AIDS, ALS and other conditions.